These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1357216)

  • 61. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
    Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
    Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA ploidy and proliferating cell nuclear antigen in islet cell tumors.
    Tomita T
    Pancreas; 1996 Jan; 12(1):36-47. PubMed ID: 8927618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
    J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proliferative activity and cytometric characteristics in polyps of the nasal cavity and paranasal sinuses.
    Welkoborsky HJ; Portmann K; Hoffmann F; Jacob R; Mann WJ; Amedee RG
    Am J Rhinol; 2000; 14(2):87-91. PubMed ID: 10793910
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 68. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
    Schammel DP; Bocklage T
    Int J Gynecol Pathol; 1996 Apr; 15(2):158-66. PubMed ID: 8786206
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
    Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
    Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of proliferative activity using antiproliferating cell nuclear antigen antibody in colorectal cancer.
    Nakae S; Nakamura T; Shirono J; Yoshioka H; Ikegawa R; Miyamura K; Kawasaki K; Saitoh Y; Tabuchi Y
    J Surg Oncol; 1995 Nov; 60(3):149-53. PubMed ID: 7475063
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A study on the relationship between clinicopathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53 and nm 23].
    Shiroko T; Saji S; Kawaguchi Y; Kageyama T; Kunieda K; Umemoto T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():118-23. PubMed ID: 7611773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
    Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
    Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
    [TBL] [Abstract][Full Text] [Related]  

  • 73. DNA hypomethylation of proliferating cell nuclear antigen gene in human hepatocellular carcinoma is not due to cell proliferation.
    Liu YW; Chang KJ; Liu YC
    Cancer Lett; 1993 Jul; 70(3):189-96. PubMed ID: 8102592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [DNA ploidy pattern in resected human hepatocellular carcinomas from the view point of biological malignant potential].
    Saiki I; Une Y; Shimamura T; Uchino J
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():135-42. PubMed ID: 8678556
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.
    Hirano T; Franzén B; Kato H; Ebihara Y; Auer G
    Am J Pathol; 1994 Feb; 144(2):296-302. PubMed ID: 7906095
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck.
    Jones AS; Roland NJ; Caslin AW; Cooke TG; Cooke LD; Forster G
    J Laryngol Otol; 1994 Oct; 108(10):859-64. PubMed ID: 7989834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
    Adachi E; Hashimoto H; Tsuneyoshi M
    Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
    Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.